FDA issued a Warning Letter to Lonza Biologics, Inc. on 9/1/2011 as a result of this inspection.
483 Lonza Biologics May 2011

483 Lonza Biologics May 2011

Debra Emerson FDA, Rory Geyer FDA$119.00 - Available Now

FDA investigators audited the Lonza Biologics - Hopkinton, MA, United States facility and issued inspectional observations (via FDA 483) on 06 May 2011.

Product details

  • Category: Human Drugs
  • Inspection end: 06 May 2011
  • Location: Hopkinton, United States
  • FEI: 3001701602
Add To Cart